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Abstract Ubiquitin carboxy-terminal hydrolase L1
(UCH-L1), also known as PGP9.5, is a protein of 223
amino acids. Although it was originally characterized as a
deubiquitinating enzyme, recent studies indicate that it also
functions as a ubiquitin (Ub) ligase and a mono-Ub stabi-
lizer. It is highly abundant in brain, constituting up to 2%
of total brain proteins. Down-regulation and extensive
oxidative modiﬁcation of UCH-L1 have been observed in
the brains of Alzheimer’s disease (AD) and Parkinson’s
disease (PD) patients. Mutations in the UCH-L1 gene have
been reported to be linked to Parkinson’s disease, in par-
ticular, the I93 M variant is associated with a higher sus-
ceptibility of PD in contrast to a higher protection against
PD for the S18Y variant. Hence, the structure of UCH-L1
and the underlying effects of disease associated mutations
on the structure and function of UCH-L1 are of consider-
able interest. Here, we report the NMR spectral assign-
ments of the S18Y human UCH-L1 mutant with the aim to
obtain better understanding about the risk of Parkinson’s
disease against structural and dynamical changes induced
by this mutation on UCH-L1.
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Biological context
Themechanismofproteinmetabolisminlivingcellsthrough
the proteasome system, ubiquitination, and deubiquitination
is an important biological process. In particular, deubiqui-
tination is considered essential for negative regulation of
proteolysisandforrecyclingofubiquitinfrompolyubiquitin
chains. Ubiquitin C-terminal hydrolase (UCH-L1), a multi-
functional 24.8 kDa protein, is one of the most abundant
proteins in the brain (1–2% of the total soluble protein)
(Wilkinsonetal.1989).MutationsintheUCH-L1genehave
been reported to be linked to susceptibility to and protection
from Parkinson’s disease (PD) (Leroy et al. 1998; Maraga-
nore et al. 1999). Furthermore, abnormal overexpression of
UCH-L1 has been shown to correlate with several forms of
cancer (Hibi et al. 1998). The I93 M UCH-L1 mutant linked
to higher susceptibility to PD was found to cause the accu-
mulation of a-synuclein in cultured cells, which is an effect
that cannot be explained by its originally recognized de-
ubiquitinating hydrolase activity. Subsequently, UCH-L1
was shown to exhibit an unexpected concentration depen-
dent ubiquitin ligase activity (Liu et al. 2002) and a mono-
ubiquitin stabilizer activity (Osaka et al. 2003). On the
contrary, a polymorphic variant of UCH-L1, S18Y, that is
associated with decreased PD risk has been shown to have a
reduced ligase activity but comparable hydrolase activity as
the wild-typeenzyme.Thus,the ligaseactivityaswell asthe
hydrolaseactivityofUCH-L1mayplayaroleinproteasomal
protein degradation in the brain, which is a critical process
for neuronal health.
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DOI 10.1007/s12104-011-9292-7The amino acid sequence of UCH-L1 is similar to that
of other ubiquitin C-terminal hydrolases, including the
ubiquitously expressed UCH-L3, which shares the con-
served catalytic residues and 51% sequence identity with
UCH-L1. But UCH-L3 appears to be unconnected to
neurodegenerative disease. Therefore, the structure of
UCH-L1 and the effects of disease associated mutations on
the structure and function of UCH-L1 are of considerable
interest and importance. Indeed, a recent small-angle
neutron scattering study indicated that the I93 M mutation
promotes ellipsoidal deformation by a decrease of the b-
turn contents whereas the S18Y mutation recovers the
globularity of the protein by an increase of b-turns (Naito
et al. 2006). As a ﬁrst step to provide detailed structural
information on molecular level and enable greater under-
standing of how the structure of these UCH-L1 mutants
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Fig. 1
1H–
15N HSQC spectrum
acquired at 298 K on a Bruker
Avance 600 MHz spectrometer
showing the assignments for
UCH-L1-S18Y. The backbone
1H–
15N correlations are
sequence-speciﬁcally labeled
and the Asn and Gln side-chain
NH2 peaks are linked by
horizontal solid lines. The
central region of the spectrum
a is expanded and shown in
b for clarity
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123relates to the etiology of PD, we present here the backbone
and side chain assignments of the S18Y human UCH-L1
mutant.
Methods and experiments
Cloning, expression, and puriﬁcation
Full-length UCH-L1 was cloned into a pET-22b vector by
using standard cloning protocols. The resulting C-terminal
(His)6-tagged protein was expressed in Escherichia coli
strain BL21(DE3) (Novagen) using M9 minimal media
supplemented with 2.0 g/l [U-
13C] glucose and 1.0 g/l
15NH4Cl (Cambridge Isotopes Laboratory) as the sole
nitrogen and carbon sources. Bacterial cultures were grown
at 37C to an optical density of 0.6–0.7. After 0.2 mM
IPTG induction at 22C for 16 h, the protein was then
puriﬁed with a nickel-nitrilotriacetic acid column (Qiagen)
following the manufacturer’s recommendations. The pro-
tein was further puriﬁed by size exclusion chromatography
on a HiLoad 16/60 Superdex 75 prep grade column
(Amersham Pharmacia). The purity of the (His)6-tagged
protein was estimated to be over 95% by SDS–PAGE.
NMR experiments
The samples were prepared in a buffer containing 20 mM
sodium phosphate, pH 6.5; 100 mM NaCl; 2 mM DTT and
1 mM PMSF in 90% H2O/10% D2O. All NMR experiments
were conducted at 298 K on a Bruker Advance 600 MHz
NMR spectrometer equipped with a TCI cryoprobe. A 2D
{
15N,
1H}-HSQC and a series of triple resonance experi-
ments including 3D HNCACB, 3D CBCA(CO)NH,
3D HNCO, 3D HNCACO, 3D HNCA, 3D HNCOCA, 3D
HBHA(CO)NH as well as 3D HCCH-TOCSY and 3D
HCCH-COSY experiments have been carried out to allow
sequence speciﬁc backbone and side-chains resonance
assignments of the protein. Trimethylsilyl propanoate (TSP)
was used as a chemical shift reference for
1H while
13C
and
15N chemical shifts were referenced indirectly, using
the gyromagnetic ratios of
15N,
13C and
1H(
15N/
1H =
0.101329118,
13C/
1H = 0.251449530). All NMR spectra
were processed using XWINNMR software (Bruker
GmbH). The chemical shifts of backbone and side-chain
resonances were assigned manually using SPARKY pro-
gram (Goddard and Kneller 1993).
Assignments and data deposition
A2 D
1H-
15N HSQC spectrum of UCH-L1-S18Y, with
assignment indicated, is shown in Fig. 1. The peaks
observed in this spectrum is well-dispersed, indicating that
the protein is well structured. All expected backbone
1H-
15N correlations have been assigned, with the exception
of Q84 and F162. The hexa-His tag at the C-terminus is
also unassigned due to considerable signal overlap. In total,
90.5% of all protons and 84.5% of all aliphatic carbons
have been assigned. All
1H,
15N and
13C backbone and
side-chain chemical shift assignments have been deposited
at the BMRB (http://www.bmrb.wisc.edu) and can be
accessed under the accession number 17260. Analysis of
the
1Ha,
13Ca,
13Cb and
13C’ chemical shift using Chemical
Shift Index (Wishart and Sykes 1994) is summarized in
Fig. 2. The predicted secondary structure of UCH-L1-
S18Y is largely consistent with that found in the crystal
structure of wild type UCH-L1 (Das et al. 2006).
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